WINTON GROUP Ltd Grows Position in Cardinal Health, Inc. $CAH

WINTON GROUP Ltd raised its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 394.9% during the second quarter, according to its most recent filing with the SEC. The firm owned 44,405 shares of the company’s stock after purchasing an additional 35,432 shares during the period. WINTON GROUP Ltd’s holdings in Cardinal Health were worth $10,549,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Investors Research Corp purchased a new stake in Cardinal Health during the second quarter worth $29,000. University of Texas Texas AM Investment Management Co. bought a new position in shares of Cardinal Health in the 4th quarter worth $26,000. Allied Private Wealth LLC bought a new position in shares of Cardinal Health in the 2nd quarter worth $30,000. NBH Bank purchased a new stake in shares of Cardinal Health during the 2nd quarter worth $31,000. Finally, Bank of Jackson Hole Trust bought a new stake in Cardinal Health during the fourth quarter valued at about $27,000. Institutional investors own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

CAH has been the subject of a number of recent research reports. Morgan Stanley boosted their target price on shares of Cardinal Health from $255.00 to $265.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. Citigroup raised their price target on shares of Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a report on Wednesday, August 12th. UBS Group boosted their price objective on shares of Cardinal Health from $274.00 to $280.00 and gave the stock a “buy” rating in a research note on Wednesday, August 12th. Weiss Ratings cut shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Wednesday, August 19th. Finally, Royal Bank Of Canada started coverage on shares of Cardinal Health in a research note on Wednesday, August 19th. They issued an “outperform” rating and a $276.00 target price for the company. Sixteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $266.56.

Insider Activity

In related news, insider Jessica Mayer sold 29,436 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total value of $6,952,488.84. Following the sale, the insider owned 33,076 shares in the company, valued at $7,812,220.44. This represents a 47.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jason Hollar sold 44,529 shares of the stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $236.18, for a total transaction of $10,516,859.22. Following the completion of the transaction, the chief executive officer owned 190,603 shares in the company, valued at approximately $45,016,616.54. This trade represents a 18.94% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 210,271 shares of company stock valued at $49,626,657. 0.12% of the stock is owned by insiders.

Cardinal Health Stock Down 0.1%

CAH stock opened at $240.31 on Thursday. The stock has a market capitalization of $55.89 billion, a PE ratio of 33.24, a price-to-earnings-growth ratio of 1.45 and a beta of 0.51. Cardinal Health, Inc. has a 52 week low of $145.87 and a 52 week high of $258.30. The firm has a 50 day moving average of $234.52 and a 200 day moving average of $219.55.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business had revenue of $63.67 billion during the quarter, compared to analysts’ expectations of $65.15 billion. During the same quarter last year, the company posted $2.08 earnings per share. The business’s quarterly revenue was up 5.8% on a year-over-year basis. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, equities research analysts expect that Cardinal Health, Inc. will post 12.55 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be paid a $0.5158 dividend. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Thursday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 28.49%.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company that supports the pharmaceutical and medical industries. Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, over-the-counter products and consumer health items to pharmacies, hospitals, health systems and other healthcare providers. The segment also provides specialty pharmaceutical services, nuclear and radiopharmaceutical products, and related support for manufacturers and providers.

Through its Global Medical Products and Distribution segment, Cardinal Health manufactures, sources and distributes medical and surgical products, including gloves, gowns, syringes, exam-room supplies and other essential equipment.